bradyarrhythmias and pacemakers

in review 7 min read Updated 2026-11-09
bradyarrhythmias and pacemakers

Two questions: where is the block (sinus node, AV node, or infranodal His–Purkinje) and is it reversible (drugs, ischaemia, hyperkalaemia, Lyme, hypothyroidism, vagal tone). Sinus node dysfunction → pace only if symptoms correlate. Infranodal block (Mobitz II, high-grade, complete heart block) → pace regardless of symptoms once reversible causes are excluded. Unstable → atropine, then adrenergic infusion or pacing; atropine fails (or worsens) infranodal block.

symptomatic bradycardia / high-grade AV block — admission bundle
  • 12-lead ECG, telemetry, transcutaneous pads on
  • reversible causes: drugs (beta-blocker, CCB, digoxin, antiarrhythmics), K⁺, ischaemia, hypothermia, hypothyroidism, raised ICP
  • labs: electrolytes, Cr, troponin, TSH, digoxin level if on it
  • hold AV-nodal blocking drugs
  • unstable (hypotension, ischaemia, confusion, HF): atropine 0.5–1 mg IV q3–5 min, max 3 mg
  • atropine fails or infranodal block: dopamine 5–20 mcg/kg/min, adrenaline 2–10 mcg/min, or transcutaneous pacing
  • isoproterenol 1–20 mcg/min is an option if ischaemia unlikely
  • persistent unstable bradycardia despite drugs: temporary transvenous pacing
  • heart transplant: no atropine — aminophylline or isoproterenol
  • inferior MI with AV block: asymptomatic → telemetry only; symptomatic or unstable → atropine, then aminophylline
  • inferior MI block usually resolves — no pacemaker decision before 72 h (ESC: 5 days)
  • beta-blocker/CCB overdose: calcium chloride 1–2 g IV, glucagon 3–10 mg IV, high-dose insulin with dextrose
  • digoxin toxicity: digoxin Fab
  • TTE before any device decision
  • no reversible cause: Mobitz II, high-grade or complete AV block → permanent pacemaker → bradyarrhythmias and pacemakers
symptomatic bradycardia

Bradycardia with hypotension, ischaemia, confusion or HF. Pads on; look for drugs, hyperkalaemia, ischaemia.

first
  • atropine 0.5–1 mg IV q3–5 min, max 3 mg
then / if needed
  • dopamine 5–20 mcg/kg/min or adrenaline 2–10 mcg/min, or transcutaneous pacing
  • temporary transvenous pacing if drugs fail
avoid
  • atropine in infranodal block or a transplanted heart — go straight to infusion or pacing

mechanism → management

  • AV node is vagally innervated and supplied by the RCA → nodal block (Wenckebach, inferior MI, drugs, high vagal tone) is usually narrow-escape, often transient, atropine-responsive
  • His–Purkinje has no vagal input → infranodal block (Mobitz II, wide escape, alternating BBB) is unpredictable, progresses to asystole, and atropine does not help: it speeds the sinus rate and can worsen the conduction ratio
  • Sinus node dysfunction prognosis is benign; pacing treats symptoms, not mortality → document symptom–rhythm correlation first
  • Prognosis of untreated Mobitz II / complete heart block is poor even if asymptomatic → pace without waiting for symptoms
  • chronic RV pacing = iatrogenic LBBB → pacing-induced cardiomyopathy when pacing burden is high

acute management

graph TD
    A[Symptomatic bradycardia<br/>hypotension, ischaemia, AMS, HF] --> B[Look for reversible cause<br/>drugs, K⁺, ischaemia, hypothermia, hypothyroid, ↑ICP]
    B --> C[Atropine 0.5–1 mg IV q3–5 min, max 3 mg]
    C -->|no response or infranodal block| D[Dopamine, adrenaline or isoproterenol infusion<br/>transcutaneous pacing]
    D -->|persistent| E[Temporary transvenous pacing]
    B -->|BB/CCB overdose| F[IV calcium, glucagon, high-dose insulin]
    B -->|digoxin toxicity| G[Digoxin Fab]
AgentDose
atropine0.5–1 mg IV, repeat q3–5 min, max 3 mg
dopamine5 mcg/kg/min, ↑ by 5 every 2 min, max 20
isoproterenol1–20 mcg/min infusion (avoid if ischaemia likely)
adrenaline2–10 mcg/min infusion
calcium (CCB overdose)10% calcium chloride 1–2 g IV, or calcium gluconate 3–6 g IV, every 10–20 min
glucagon (BB/CCB overdose)3–10 mg IV over 3–5 min → 3–5 mg/h
high-dose insulin (BB/CCB overdose)1 unit/kg bolus → 0.5 units/kg/h (with dextrose, K⁺ monitoring)
digoxin Fab1 vial (40 mg) binds ~0.5 mg digoxin; dialysis does not remove digoxin
aminophyllineinferior MI with AV block, post-heart-transplant, spinal cord injury
  • Heart transplant: no atropine (denervated heart → paradoxical block); use aminophylline/theophylline or isoproterenol
  • transcutaneous pacing as a bridge (sedate, confirm mechanical capture by pulse) → transvenous if refractory; not for minimal or infrequent symptoms

who gets a permanent pacemaker

sinus node dysfunction

SituationPPM
symptoms directly attributable to SNDyes
symptomatic bradycardia from essential GDMT with no alternativeyes
tachy-brady syndrome (post-AF pauses)yes — or AF ablation to avoid pacing
asymptomatic sinus bradycardia or pauses during sleepno
  • uncertain symptom correlation → ambulatory monitoring; loop recorder if symptoms <1/month
  • remove non-essential negative chronotropes first

AV block

BlockPPM
Mobitz II, high-grade, or complete heart block not due to a reversible/physiological causeyes, regardless of symptoms
AF with symptomatic bradycardia or high-grade blockyes
symptomatic block from essential GDMT/antiarrhythmicsyes
infiltrative (sarcoid) with Mobitz II or higheryes — consider ICD capability
1st-degree or Mobitz I with clearly attributable symptomsreasonable
asymptomatic 1st-degree, Mobitz I, or vagally mediated block (sleep, athletes)no
  • Reversible causes: Lyme carditis (antibiotics, temporary pacing; usually resolves in 1–2 weeks), drug toxicity, hyperkalaemia, ischaemia → treat, temporary pacing if needed. Pace if the block persists despite treatment
  • Block on stable doses of a necessary AV-nodal drug → often intrinsic disease; PPM reasonable without stopping the drug
  • unexplained AV block, especially <60 y → look for sarcoid (CMR, FDG-PET) or ATTR amyloid (PYP)

bundle branch and fascicular block (1:1 conduction)

  • new LBBB → TTE; CMR or stress imaging if structural disease or ischaemia suspected
  • syncope + bundle branch block → EPS or loop recorder → syncope
  • alternating bundle branch block → PPM
  • Asymptomatic isolated conduction disease (bifascicular block, RBBB + LAFB) → no PPM; ambulatory monitoring in selected patients

reflex syncope

  • dual-chamber PPM if age >40 with severe recurrent syncope and documented asystole (spontaneous pause, carotid sinus syndrome or tilt); never without documented asystole → reflex syncope and orthostatic hypotension

special situations

SettingApproach
acute MIinferior MI nodal block, including Mobitz I (vagal tone or AV-nodal ischaemia) → usually resolves. Asymptomatic → telemetry only; symptomatic or haemodynamically significant → atropine; temporary pacing if medically refractory. no PPM within 72 h; ESC waits ≥5 days; persistent infranodal block → PPM; block that resolves or new BBB alone → no PPM
post-TAVIhigh-grade or complete block persisting 24–48 h, or new alternating BBB → PPM; pre-existing RBBB + any new conduction disturbance → early PPM; new LBBB → monitor
post cardiac surgeryhigh-grade block → observe ≥5 days before PPM, sooner if poor escape
sleep apnoeanocturnal bradycardia/pauses → screen and treat OSA rather than pace → sleep-disordered breathing

pacing mode

  • SND or AV block in sinus rhythm → dual chamber (VVI in sinus rhythm → pacemaker syndrome: AV dyssynchrony, cannon waves, hypotension)
  • permanent AF or infrequent pacing expected → single-chamber ventricular (VVI)
  • AV block with reduced LVEF and high expected pacing burden → CRT or conduction-system pacing over RV pacing → HFrEF management
  • leadless pacemaker if no venous access or high infection risk
  • driving after PPM → fitness to drive (cardiac)

Prepared 2026-11-09. Not yet verified — check every number against the sources.

Key references

Suggest a correction bradyarrhythmias and pacemakers